Medical Bankruptcy Fairness Act of 2026
Key claim: The Medical Bankruptcy Fairness Act of 2026 (HR9670) was introduced in the 119th Congress and referred to the Judiciary and Financial Services committees to address fairness in bankruptcies driven by medical costs.
Abstract
(HR9670 · 119th Congress) Latest action (2026-07-14): Referred to the Committee on the Judiciary, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
[This finding represents 2 closely related documents issued 2026-07-14 (same source, same action). Related: congress:119-s-4972:introduced]
Why this matters
Medical debt is a leading driver of U.S. personal bankruptcies, so a fairness-focused overhaul could reshape how consumers, hospitals, and unsecured creditors are treated in Chapter 7/13 proceedings. For banks and consumer lenders, changes to medical-debt treatment in bankruptcy could affect recovery expectations on unsecured portfolios and interact with ongoing CFPB and credit-reporting reforms. Status remains introduced-only, so downstream impact is contingent on committee action.